Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Independence Blue Cross	Orthognathic SurgeryPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-083	New policy
Aug 2, 2026	Independence Blue Cross	Omalizumab (Xolair) and related biosimilarsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-025	New policy
Aug 2, 2026	Independence Blue Cross	olipudase alfa-rpcp (Xenpozyme)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-154	New policy
Aug 2, 2026	Independence Blue Cross	Off-label Coverage for Prescription Drugs and/or BiologicsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-012	New policy
Aug 2, 2026	Independence Blue Cross	Octreotide Acetate (Sandostatin LAR Depot)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-065	New policy
Aug 2, 2026	Independence Blue Cross	Ocrelizumab (Ocrevus) and Ocrelizumab and Hyaluronidase-ocsq (Ocrevus Zunovo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-088	New policy
Aug 2, 2026	Independence Blue Cross	Nusinersen (Spinraza)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-086	New policy
Aug 2, 2026	Independence Blue Cross	NucleoplastyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-101	New policy
Aug 2, 2026	Independence Blue Cross	Not Medically Necessary Services and Obsolete or Unreliable Diagnostic TestsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-001	New policy
Aug 2, 2026	Independence Blue Cross	Non-Surgical Spinal Decompression TherapyPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-021	New policy
Aug 2, 2026	Independence Blue Cross	Non-Spinal Osteogenic Stimulators (Electrical and Ultrasonic)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-018	New policy
Aug 2, 2026	Independence Blue Cross	Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver DiseasePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-024	New policy
Aug 2, 2026	Independence Blue Cross	Nonemergent Inpatient Video Electroencephalogram (EEG) Monitoring and Ambulatory EEG Monitoring in the HomePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-053	New policy
Aug 2, 2026	Independence Blue Cross	Nogapendekin alfa inbakicept-pmln (Anktiva)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-175	New policy
Aug 2, 2026	Independence Blue Cross	Nivolumab and relatlimab-rmbw (Opdualag) for intravenous usePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-152	New policy
Aug 2, 2026	Independence Blue Cross	Nivolumab (Opdivo), Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-120	New policy
Aug 2, 2026	Independence Blue Cross	Nipocalimab-aahu (Imaavy)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-187	New policy
Aug 2, 2026	Independence Blue Cross	Never Events and Preventable Serious Adverse EventsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-039	New policy
Aug 2, 2026	Independence Blue Cross	Neuropsychological Testing for Neurologically Based ConditionsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA07-038	New policy
Aug 2, 2026	Independence Blue Cross	Neuromuscular Electrical Stimulators (NMES) and Functional Electrical Stimulators (FES)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-058	New policy
Aug 2, 2026	Independence Blue Cross	Nerve Fiber Density TestingPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-023	New policy
Aug 2, 2026	Independence Blue Cross	Negative Pressure Wound Therapy SystemsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-008	New policy
Aug 2, 2026	Independence Blue Cross	Nebulizers and Inhalation SolutionsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA05-007	New policy
Aug 2, 2026	Independence Blue Cross	Natalizumab (Tysabri) and Related BiosimilarsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-029	New policy
Aug 2, 2026	Independence Blue Cross	Musculoskeletal ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-047	New policy
Aug 2, 2026	Independence Blue Cross	Multiple Surgery Payment ReductionPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-032	New policy
Aug 2, 2026	Independence Blue Cross	Multiple Procedure Payment Reduction Guidelines for Physical, Occupational, and Speech Therapy ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-050	New policy
Aug 2, 2026	Independence Blue Cross	Multiple Procedure Payment Reduction (MPPR) on Certain Diagnostic ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA01-005	New policy
Aug 2, 2026	Independence Blue Cross	Multiple Procedure Payment Reduction (MPPR) Guidelines for Transvaginal and Transabdominal UltrasoundsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-057	New policy
Aug 2, 2026	Independence Blue Cross	Mosunetuzumab-axgb (Lunsumio)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-158	New policy
Aug 2, 2026	Independence Blue Cross	Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's DiseasePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-151	New policy
Aug 2, 2026	Independence Blue Cross	Molecular DiagnosticsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA06-017AA-F524CC52A9	New policy
Aug 2, 2026	Independence Blue Cross	Mohs Micrographic Surgery (MMS)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA11-018	New policy
Aug 2, 2026	Independence Blue Cross	Mogamulizumab-kpkc (Poteligeo)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA08-102	New policy
Aug 2, 2026	Independence Blue Cross	Modifiers XE, XP, XS, XU, and 59PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-005	New policy
Aug 2, 2026	Independence Blue Cross	Modifiers for Shared or Split Surgical Services (Modifiers 54, 55, 56)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-017	New policy
Aug 2, 2026	Independence Blue Cross	Modifiers for Assistant-at-Surgery Services: 80, 81, 82, and ASPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-015	New policy
Aug 2, 2026	Independence Blue Cross	Modifiers 26 (Professional Component) and TC (Technical Component)PayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-011	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 79: Unrelated Procedure or Service by the Same Physician or Other Qualified Health Care Professional During the Postoperative PeriodPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-012	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 78: Unplanned Return to the Operating/Procedure Room by the Same Physician or Other Qualified Health Care Professional Following Initial Procedure for a Related Procedure During the Postoperative PeriodPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-008	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 77: Repeat Procedure or Service by Another Physician or Other Qualified Health Care ProfessionalPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-007	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 76: Repeat Procedure or Service by Same Physician or Other Qualified Health Care ProfessionalPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-001	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 66: Surgical TeamPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-014	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 62: Two SurgeonsPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA00-011	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 57:  Decision for SurgeryPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-010	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 53: Discontinued ProcedurePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-018	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 52: Reduced ServicesPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-014	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 50: Bilateral ProcedurePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-002	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 25: Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other ServicePayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-003	New policy
Aug 2, 2026	Independence Blue Cross	Modifier 24: Unrelated Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional During a Postoperative PeriodPayerPolicy · IBX-MEDICARE-ADVANTAGE-MA03-009	New policy